Concepedia

Megan Kalpakoff

MK

Statistics

Publications

1

Citations

28

H-Index

1

Active since

2021

Affiliations

Agilent Technologies (Germany)(Current)

Megan Kalpakoff is an author at Agilent Technologies (Germany) specializing in medicine, pembrolizumab therapy, and tumor heterogeneity.

Publications per year

2021–2021

1

Publications

1

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx

Megan Kalpakoff, Stephanie Hund, Jeanette Musser et al. · Applied immunohistochemistry & molecular morphology · 2021 · 28 citations · Full text

, , +14

1–1 of 1